2012-09-17 06:05:18 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's pharmaceuticals report, "Patrys Limited - Product Pipeline Review - 2012" provides data on the Patrys Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Patrys Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Patrys Limited and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Patrys Limited - Brief Patrys Limited overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Patrys Limited human therapeutic division.
* Overview

of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Patrys Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Patrys Limited's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/463634_patrys_limited_product_pipeline_revie ..


Reasons to buy

* Evaluate Patrys Limited's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Patrys Limited in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Patrys Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Patrys Limited.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Patrys Limited and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Patrys Limited; Patrys Limited - Key Therapeutics; Patrys Limited - Pipeline Overview and Promising Molecules; Patrys Limited - News; Patrys Limited - Latest Updates; Patrys Limited - Pipeline; Patrys Limited - Discontinued/Dormant Projects

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Patrys Limited Snapshot
Patrys Limited Overview
Key Information
Key Facts
Proximagen Group plc - Research and Development Overview
Key Therapeutic Areas
Proximagen Group plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Proximagen Group plc - Pipeline Products Glance
Proximagen Group plc Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Proximagen Group plc - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Proximagen Group plc - Drug Profiles
250 Back-up Abs
Product Description
Mechanism of Action
R&D Progress
Infectious Disease Abs
Product Description
Mechanism of Action
R&D Progress
PAT-CSL1
Product Description
Mechanism of Action
R&D Progress
PAT-CSL2
Product Description
Mechanism of Action
R&D Progress
PAT-CSL3
Product Description
Mechanism of Action
R&D Progress
PAT-CSL4
Product Description
Mechanism of Action
R&D Progress
PAT-LM1
Product Description
Mechanism of Action
R&D Progress
PAT-NM1
Product Description
Mechanism of Action
R&D Progress
PAT-NM2
Product Description
Mechanism of Action
R&D Progress
PAT-SC1
Product Description
Mechanism of Action
R&D Progress
PAT-SM3
Product Description
Mechanism of Action
R&D Progress
PAT-SM5
Product Description
Mechanism of Action
R&D Progress
PAT-SM6
Product Description
Mechanism of Action
R&D Progress
Proximagen Group plc - Pipeline Analysis
Proximagen Group plc - Pipeline Products by Therapeutic Class
Proximagen Group plc - Pipeline Products by Route of Administration
Proximagen Group plc - Pipeline Products By Mechanism of Action
Proximagen Group plc - Recent Pipeline Updates
Proximagen Group plc - Dormant Projects
Proximagen Group plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Proximagen Group plc, Recent Developments
Proximagen Group plc- Press Release
May 24, 2012: Patrys Obtains US Patent For Cancer Drug, PAT-SM6
Mar 20, 2012: Patrys Announces Successful Phase I Clinical Trial For PAT-SM6
Feb 09, 2012: Patrys Successfully Completes Phase I Trial Of PAT-SM6 For Melanoma
Oct 06, 2009: Patrys Acquires Human Antibody Shown to Provide Survival Benefit to Gastric Cancer Patients
Sep 16, 2009: Lead Products PAT-SM6 Demonstrates Therapeutic Potential As Treatment For Human Colon Cancer.
Aug 24, 2009: Patrys Completes Preclinical Safety Analysis For PAT- LM1
May 25, 2009: Patrys Announces Initiation of Safety Studies for PAT-LM1
May 25, 2009: Patrys Announces Initiation Of Safety Studies For PAT-SM6
Financial Deals Landscape
Patrys Limited, Deals Summary
Patrys Limited, Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Patrys Acquires PAM-1 From Debiopharm Group
Patrys Acquires Rights Of SC1 From Debiovision
Patrys Acquired Three Product Pipelines From OncoMab And Acceptys

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463634&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.